Page 9 - Read Online

Page 14 Bote et al. One Health Implement Res 2023;3:11-5 https://dx.doi.org/10.20517/ohir.2022.46

DECLARATIONS
Authors’ contributions
Conceptualization and writing this comment: Bote K, Nadal D, Abela B
Conceptualization, writing - original draft: Bote K
Conceptualization, writing - review & editing: Nadal D
Conceptualization, writing - review & editing: Abela B
All authors read and approved the final manuscript.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2023.

REFERENCES
1. Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis
2015;9:e0003709. DOI PubMed PMC
2. World Health Organization, Food and Agriculture Organization of the United Nations and World Organisation for Animal Health.
Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030. Available from: https://apps.who.int/iris/
handle/10665/272756 [Last accessed on 20 Mar 2023].
3. Gavi, The Vaccine Alliance. Vaccine investment strategy. Available from: https://www.gavi.org/our-alliance/strategy/vaccine-
investment-strategy [Last accessed on 20 Mar 2023].
4. World Health Organization. Guide to introducing human rabies vaccine into national immunization programmes. Available from:
https://apps.who.int/iris/handle/10665/360978 [Last accessed on 20 Mar 2023].
5. World Health Organization. Rabies vaccines: WHO position paper - April 2018 - vaccins antirabiques: note de synthèse de l’OMS -
avril. Available from: https://apps.who.int/iris/handle/10665/272372 [Last accessed on 20 Mar 2023].
6. World Health Organization. WHO expert consultation on rabies: third report. Available from: https://apps.who.int/iris/handle/10665/
272364 [Last accessed on 20 Mar 2023].
7. Cantaert T, Borand L, Kergoat L, et al. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2):
an observational cohort study. Lancet Infect Dis 2019;19:1355-62. DOI PubMed
8. Kessels J, Tarantola A, Salahuddin N, Blumberg L, Knopf L. Rabies post-exposure prophylaxis: a systematic review on abridged
vaccination schedules and the effect of changing administration routes during a single course. Vaccine 2019;37 Suppl 1:A107-17. DOI
PubMed
9. World Health Organization. Strategic advisory group of experts on immunization (SAGE) - October 2017. Available from: https://
www.who.int/news-room/events/detail/2017/10/17/default-calendar/strategic-advisory-group-of-experts-on-immunization-(sage)---
october-2017 [Last accessed on 20 Mar 2023].
10. Hampson K, Abela-Ridder B, Bharti O, et al. Modelling to inform prophylaxis regimens to prevent human rabies. Vaccine 2019;37
Suppl 1:A166-73. DOI PubMed PMC
11. Nadal D, Abela-ridder B, Beeching S, et al. The impact of the first year of the COVID-19 Pandemic on canine rabies control efforts: a
mixed-methods study of observations about the present and lessons for the future. Front Trop Dis 2022;3:866811. DOI
12. World Health Organization. Global market study: human rabies vaccines. Available from: https://www.who.int/publications/m/item/